The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.

about

The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.

Item

http://www.wikidata.org/entity/Q47159355

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The risk of malignancy and its ...... treated with biologic DMARDs.

@en

The risk of malignancy and its ...... treated with biologic DMARDs.

@nl

type

Item

label

The risk of malignancy and its ...... treated with biologic DMARDs.

@en

The risk of malignancy and its ...... treated with biologic DMARDs.

@nl

prefLabel

The risk of malignancy and its ...... treated with biologic DMARDs.

@en

The risk of malignancy and its ...... treated with biologic DMARDs.

@nl

P1476

The risk of malignancy and its ...... treated with biologic DMARDs.

@en

P2093

Jiyoung Lee

http://www.w3.org/2001/XMLSchema#string

Soo-Kyung Cho

http://www.w3.org/2001/XMLSchema#string

Yoon-Kyoung Sung

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea.

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials.

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.

Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm data.

The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.

Korea's thyroid-cancer "epidemic"--screening and overdiagnosis.

Chronic inflammation and cancer.

P2888

s13075-017-1482-y

P304

277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-017-1482-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sang-Cheol Bae

Minkyung Han

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099677404

http://www.w3.org/2001/XMLSchema#string

P698

29246243

http://www.w3.org/2001/XMLSchema#string

P932

5732524

http://www.w3.org/2001/XMLSchema#string